Article Information
History
- February 23, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- J. J.J.M. Stohr1,2,3,*,
- V. F. Zwart1,2,3,
- G. Goderski4,
- A. Meijer4,
- C. R.S. Nagel-Imming1,
- M.F.Q. Kluytmans-van den Bergh1,5,6,
- S. D. Pas2,3,
- F. van den Oetelaar7,
- M. Hellwich7,
- K. H. Gan7,
- A. Rietveld7,
- J.J. Verweij3,
- J. L. Murk2,3,
- W. van den Bijllaardt1,2 and
- J. A. J. W. Kluytmans1,2,3,5,6
- 1Department of Infection Control, Amphia Hospital, Breda, the Netherlands
- 2Microvida Laboratory for Medical Microbiology, Amphia Hospital, Breda, the Netherlands
- 3Microvida Laboratory for Medical Microbiology and immunology, Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands
- 4National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
- 5Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, the Netherlands
- 6Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 7Municipal Health Services GGD Hart voor Brabant, ‘s-Hertogenbosch, the Netherlands
- ↵*Corresponding author e-mail: joep.stohr{at}gmail.com, Telephone number: +31765953015
Posted February 23, 2021.
Self-testing for the detection of SARS-CoV-2 infection with rapid antigen tests
